CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies ...
CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary recombinant human collagen (rhCollagen) ...
CollPlant is now moving towards clinical trials and scaling and optimizing its manufacturing to ensure readiness for the upcoming clinical trials REHOVOT, Israel, Sept. 30, 2025 /PRNewswire/ -- ...
Please provide your email address to receive an email when new articles are posted on . Two calcium hydroxyapatite-based derma fillers were compared. Filler suspended in carboxymethylcellulose induced ...
16d
Dermal Fillers Market Forecast 2026-2036: Global Revenue to Reach USD 9.9 Billion by 2036 at 3.2%
Dermal Fillers Market Forecast 2026-2036: Global Revenue to Reach USD 9.9 Billion by 2036 at 3.2% ...
Pompano Beach Clinic Details Non-Surgical Tear Trough Rejuvenation Options Pompano Beach, United States – February 18, 2026 / ...
An international team led by National University of Singapore researchers has linked secondary lymphedema to excessive cholesterol buildup inside skin and around lymphatic vessels. Excess cholesterol ...
Michael Freeman is the founder of The Skin Centre, a private dermatology practice which also offers dermal fillers. Fillers are now one of the most common non-surgical cosmetic procedures. Adding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results